Platelet Adhesion Proteins and Ligands

Click on one of the choices in the Explore Pathways box to view a different Platelet pathway.
Activated Integrin
alpha 2 beta 1
Activated Integrin
alpha 2b beta 3
Activated Integrin
alpha 5 beta 1
Activated Integrin
alpha 6 beta 1
ProductsClose
GPVI
ProductsClose
FCER1G
GPIb
ProductsClose
GPIX
ProductsClose
Glycoprotein V
ProductsClose
G6b
G6b
ProductsClose
G6b
CLEC-2
ProductsClose
CD36/SR-B3/
GPIIIb
ProductsClose
P-Selectin/
CD62P
CD40 Ligand/
TNFSF5
Ligands of Activated
Adhesion Proteins
Collagen
C1q
Decorin
ProductsClose
E-Cadherin
ProductsClose
Laminin
Fibrinogen
ProductsClose
Fibronectin
Plasminogen
Prothrombin
Thrombospondin
Vitronectin
ProductsClose
Fibronectin
Laminin
Collagen
Collagen
Factor XI, XII
Kininogen
P-Selectin
Thrombin
vWF-A2
ProductsClose
Heparin
ProductsClose
Podoplanin
Rhodocytin
ProductsClose
Thrombospondin
PSGL-1/CD162
CD40/TNFRSF5
Extracellular matrix molecules are exposed in damaged vascular endothelium.
Platelet adhesion to endothelium is stabilized by activated integrin binding.
Ligands are expressed on leukocytes.
Adhesion does not require interaction with vasculature.
Interaction promotes leukocyte activation.
Platelet Adhesion Proteins and Ligands

Overview of Platelet Adhesion Proteins and Ligands

Platelets adhere to the vascular endothelium at sites of endothelial injury where extracellular matrix (ECM) components in the sub-endothelial space are exposed to the circulation. GP family glycoproteins mediate rapid tethering to ECM molecules at these sites. Integrin heterodimers become activated and then provide robust platelet adhesion. Adhesion is an early phase of platelet activation and limits bleeding by promoting platelet aggregation and clot formation (thrombosis). Circulating molecules, such as vWF-A2 and Thrombospondin also contribute to platelet aggregate formation. In addition, platelets can form circulating aggregates with monocytes and leukocytes to enhance systemic inflammatory responses.